Just received this article in a newsletter which talks about ketamine closures in US. Don’t shoot the messenger but I think it is good to be aware of this industry context in relation to our recent Ann.
https://psychedelicalpha.com/news/psychedelic-bulletin-133-ketamine-clinics-close-with-potential-repercussions-for-pat-roll-out-psychedelics-at-sxsw-could-mdma-be-among-first-beneficiaries-of-faster-uk-drug-approvals
No advice. DYOR.